Wai Yuen Tong Medicine Holdings Ltd
Company Profile
Business description
Wai Yuen Tong Medicine Holdings Ltd is principally engaged in the manufacturing and sale of traditional Chinese pharmaceutical and health food products and relevant services, the manufacturing and sale of Western pharmaceutical, health food and personal care products, and property investment. The Group operates through the Chinese Pharmaceutical segment, which includes the manufacture, processing and sale of traditional Chinese medicine, Chinese medicinal products, health food products, TCM outpatient clinic services, and management and promotion services; the Western Pharmaceutical segment; and the Property Investment segment. The Chinese Pharmaceutical segment generates the maximum revenue, and the Group generates the maximum revenue from Hong Kong.
Contact
39 Wang Kwong Road
Suite 3101, 31st Floor, Skyline Tower
Kowloon Bay, Kowloon
Hong Kong
HKGT: +852 23128202
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
691
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
stocks
ASX listed media giant drives strong earnings growth
stocks
ASX real estate platform outperforms yet questions remain
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,718.78 | 3.85 | 0.04% |
| DAX 40 | 26,344.23 | 24.78 | 0.09% |
| Dow JONES (US) | 53,933.13 | 103.80 | -0.19% |
| FTSE 100 | 10,860.17 | 40.92 | -0.38% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,610.12 | 80.50 | -0.30% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,750.33 | 7.31 | -0.09% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |